Whac-A-Mole drug policy

Whac-A-Mole drug policy is the reactive cycle in which authorities target one drug, formulation, or supply route only for another to emerge, while the underlying drivers of addiction and the barriers to care persist. In the book, the metaphor links changing opioid supplies to uneven enforcement and stop-start local responses: a policy can move the problem without resolving it, and people in need may be left waiting while institutions try to coordinate.

The cycle of substitution

The pattern appears in the changing opioid supply. Restrictions on popular painkillers and the rescheduling of hydrocodone occurred against a backdrop of opioid prescriptions that had quadrupled. As prescribing rules tightened, the book also follows the emergence of illicitly imported fentanyl. Each time authorities banned a chemical derivative, underground producers developed new potent opioids faster than officials could respond. Enforcement aimed at a particular substance could therefore be overtaken by the next version of the supply.

The earlier OxyContin story shows a different kind of regulatory mismatch. The 1995 application reviewed by Curtis Wright described how crushing a tablet could release the drug immediately, reported withdrawal symptoms among some clinical-trial patients, and stated that 68 percent of the oxycodone in one crushed pill could be recovered for injection. Purdue Pharma later claimed it had not known of abuse problems until February 2000. The contrast places the limits of reactive oversight in view: significant risks were documented before the drug’s wider abuse became a public concern, while the approval summary’s caution about competitive promotion did not prevent aggressive promotion.

Enforcement and unequal consequences

The book’s account of Roanoke’s earlier heroin market also complicates the idea that drug policy acts evenly. Heroin was largely treated as a matter for police and court reporters and was commonly imagined as an inner-city drug. Don Wolthuis described a small, mostly African American group of users and dealers whose lives were widely perceived as isolated and invisible. That history contrasts with later public language about opioid addiction as a problem that could not be solved through arrests alone.

The contrast becomes sharper in the account of Ronnie Jones’s imprisonment and the wider criminal-justice system. The book notes that three-quarters of federal drug offenders were Black or Hispanic and that people of color made up 57 percent of state-imprisoned drug offenders, even as calls to avoid arrest-centered responses were often directed toward mostly white opioid users. It also cites Centers for Disease Control and Prevention data showing that doctors prescribed painkillers to people of color at far lower rates than to white patients, amid distrust that they would misuse them. The resulting pattern is not a simple story of one drug being replaced by another: access to medication, exposure to addiction, and the consequences of drug enforcement were distributed unequally.

The book further connects the cycle to the conditions of reentry. Ronnie’s repeated imprisonment illustrates how a criminal record can obstruct legitimate work and return people to a loop of joblessness and incarceration. In contrast, the Equal Justice Initiative model described in the book sends clients to places such as Seattle, where diversion from prosecution can be paired with housing, case management, employment help, and harm reduction. This approach aims not only to support people leaving prison but also to reduce the economic pressure that can sustain drug dealing.

Treatment as a handoff problem

In Roanoke, a different form of policy failure appeared between overdose reversal and ongoing care. Hope Initiative volunteers, or angels, were meant to guide people toward treatment and connect them with housing, mental-health, and employment resources. The program was based at the Bradley Free Clinic. Its work reflected an attempt to respond nimbly, but a referral was not the same as access: local organizers faced too few medication-assisted treatment providers, too few detox and treatment beds, and bureaucratic, financial, and legal barriers to transferring patients from emergency care into follow-up treatment.

The first month made the gap measurable. Twenty-two people came to Hope, but none entered residential treatment and only a handful obtained outpatient medication-assisted treatment. The effort depended on repeated expressions of interest and continued contact, while treatment capacity remained scarce. The book describes this mismatch as a crisis of implementation: local volunteers could identify people ready to accept help, but they could not by themselves create beds or providers.

The attempted transfer of John from detox shows how much personal coordination could be required to cross that gap. A Hope volunteer working with John’s father arranged an out-of-state treatment placement; Janine Underwood coaxed the detox center to keep John for an extra day and organized a family intervention elsewhere because the center would not allow it on its premises. His father hired an interventionist, and the family arranged a meeting under the pretext that John was signing up for outpatient counseling. The episode makes the narrowness of the opportunity for treatment concrete: the transfer depended on improvised help and a short window, rather than a smooth, routine connection between services.

A policy metaphor with limits

The book does not present every intervention as equivalent. It distinguishes enforcement directed at supply from approaches that connect people to care, and it shows that even treatment-oriented initiatives can be undermined by shortages and fragmented systems. The Hope Initiative’s volunteers and the diversion model described by the Equal Justice Initiative offer alternatives to arrest, but their effectiveness depends on resources and durable coordination rather than good intentions alone.

The metaphor’s force lies in its repeated reversals: restrict one medication and illicit supply can shift; ban one synthetic derivative and another can appear; call for treatment while leaving too few providers and beds to deliver it. The cycle is not merely a sequence of substances. It also describes how policy can react to visible symptoms while preserving the unequal conditions and institutional gaps that help the crisis endure.